ArticleJournal of cerebrovascular and endovascular neurosurgery2026
Predicting subdural hematoma outcomes as a function of PACE score.
Article in Journal of cerebrovascular and endovascular neurosurgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the relationship between the Patency after Coil Embolization (PACE) score and subdural hematoma resolution as defined by reduction in hematoma cross-sectional area. Methods: Patients with standalone coil middle meningeal artery embolization for subdural hematoma treatment were included in this study. Hematoma cross-sectional area (CSA) of the largest preoperative computed tomography (CT) slice and the corresponding postoperative CT slice, average Hounsfield units, and days between embolization and follow-up were recorded for each patient. A receiver operating characteristic (ROC) curve was used to determine the optimal threshold of hematoma resolution percentage at follow-up to differentiate between PACE score 0 and PACE score 1 embolizations. A multivariate logistic regression model of resolution above the calculated threshold adjusted for follow-up time, initial hematoma CSA, average Hounsfield units, and the PACE score was created. Results: A total of 43 patients with 63 hematomas (20 patients had bilateral hematomas) were included in this study. ROC curve calculated threshold for hematoma resolution was 70.9%. There were univariate statistically significant differences in follow-up time and hematoma size (p=0.021, p=0.006, respectively). In the multivariate model, the PACE score was the only statistically significant predictor of at least 70.9% hematoma resolution at follow-up. Conclusions: The PACE score is the most statistically significant predictor of at least 70.9% hematoma resolution at follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.